Table 2.
Biological function | Exosomal ncRNAs | Expression levels in macrophages and their exosomes | Potential direct target gene(s) of ncRNAs in tumor cells | Mechanism | Cancer type | Ref. |
---|---|---|---|---|---|---|
Tumor cell proliferation | miR-95 | high | JunB↓ | promote tumor progression by binding directly to its downstream target gene JunB to promote PCa cell proliferation, invasion, and EMT | PCa | Guan et al.87 |
miR-21 | high | PDCD4↓ | promote tumor progression by targeting the PDCD4 gene and inhibiting PDCD4 expression to prevent apoptosis in GC cells | GC | Wang et al.88 | |
lncRNA LIFR-AS1 | high | miR-29a↓ | act as a miR-29a sponge to upregulate NFIA, promoting tumor cell proliferation but inhibiting tumor cell invasion and apoptosis | osteosarcoma | Zhang et al.89 | |
miR-221-3p | high | CDKN1B↓ | directly target and inhibit CDKN1B expression to promote EOC cell proliferation and G1/S conversion | EOC | Li and Tang90 | |
miR-142 miR-223 |
high | STMN1 and IGF-1R↓ | downregulate the expression of reporter proteins and endogenously expressed stathmin-1 and insulin-like growth factor-1 receptor at the post-transcriptional level to inhibit tumor cell proliferation | HCC | Aucher et al.91 | |
miR-125a miR-125b |
underexpressed in exosomes | CD90↑ | target CD90 to promote HCC cell proliferation | HCC | Wang et al.92 | |
Tumor metastasis | miR-501-3p | high | TGFBR3↓ | target TGFBR3 to promote PDAC cell metastasis | PDAC | Yin et al.99 |
miR-21-5p miR-155-5p |
high | BRG1↓ | downregulate BRG1 expression by binding to the BRG1 coding sequence to promote CRC cell migration and invasion | CRC | Lan et al.100 | |
lncRNA SBF2-AS1 | high | miR-122-5p↓ | act as a ceRNA to repress miR-122-5p and upregulate XIAP to promote PC progression | PC | Yin et al.102 | |
lncRNA AFAP1-AS1 | high | miR-26a↓ | act as a ceRNA to repress miR-26a and upregulate ATF2 to promote esophageal cancer (EC) cell migration and invasion and lung metastasis | EC | Mi et al.103 | |
miR-92a-2-5p | high | AR↓ | target the 3′ UTR of AR mRNA and inhibit AR translation to alter PHLPP/p-AKT/β-catenin signaling and promote HCC cell invasion | HCC | Liu et al.104 | |
miR-223 | high | Mef2c↓ | target the Mef2c-β-catenin pathway to promote BC cell invasion | BC | Yang et al.105 | |
miR-223 | high | PTEN↓ | target the PTEN-PI3K/AKT pathway, alter the actin cytoskeleton, and upregulate multiple proteins associated with EMT to promote GC cell migration and invasion | GC | Zheng et al.106 | |
miR-7 | high after TWEAK treatment | EGFR↓ | downregulate the activity of the EGFR/AKT/ERK1/2 pathway to reduce EOC cell metastasis | EOC | Hu et al.107 | |
Tumor angiogenesis | miR-501-3p | high | TGFBR3↓ | target TGFBR3 to promote tube formation | PDAC | Yin et al.99 |
miR-130b-3p | high | MLL3↓ | promote GC progression via miR-130b-3p/MLL3/GRHL2 signaling | GC | Zhang et al.122 | |
Tumor chemoresistance | miR-21 | high | PTEN↓ | activates PI3K/AKT signaling by downregulating PTEN to inhibit GC cell apoptosis and promote DDP resistance | GC | Zheng et al.128 |
lncRNA CRNDE | high | PTEN↓ | facilitate NEDD4-1-mediated PTEN ubiquitination to increase cisplatin resistance in GC cells | GC | Xin et al.129 | |
miR-21 | high | STAT3 and PDCD4↓ | regulate the STAT3/miR-21/PDCD4 signaling pathway, which is associated with temozolomide resistance in GBM | GBM | Chuang et al.117 | |
miR-223 | high | PTEN↓ | activate downstream signaling pathways, including PI3K/AKT, through downregulating PTEN to enhance drug resistance in EOC cells under hypoxia | EOC | Zhu et al.132 | |
miR-365 | high | CDA↑ | upregulate the triphosphate-nucleotide pool and induce the enzyme cytidine deaminase in cancer cells to induce PDAC resistance to gemcitabine | PDAC | Binebaum et al.133 |